{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:02:06Z","timestamp":1781715726655,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["51\/C\/2019"],"award-info":[{"award-number":["51\/C\/2019"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["CTF-2023-05-001"],"award-info":[{"award-number":["CTF-2023-05-001"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002943","name":"Departament d'Innovaci\u00f3, Universitats i Empresa, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 SGR 00967"],"award-info":[{"award-number":["2021 SGR 00967"]}],"id":[{"id":"10.13039\/501100002943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["NF200051"],"award-info":[{"award-number":["NF200051"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI21\/00063"],"award-info":[{"award-number":["FI21\/00063"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73119-8","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:01:11Z","timestamp":1781708471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induced pluripotent stem cell\u2013derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-673X","authenticated-orcid":false,"given":"Itziar","family":"Uriarte-Arrazola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2741-4572","authenticated-orcid":false,"given":"M\u00edriam","family":"Magall\u00f3n-Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-5804","authenticated-orcid":false,"given":"Juana","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-1040","authenticated-orcid":false,"given":"Jiajing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ortega-Bertran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Creus-Bachiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9486-9660","authenticated-orcid":false,"given":"Judit","family":"Farr\u00e9s-Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2636-2766","authenticated-orcid":false,"given":"Kelli M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9946-5922","authenticated-orcid":false,"given":"Katlin","family":"Recabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-7481","authenticated-orcid":false,"given":"Ignacio","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-6882","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleof\u00e9","family":"Romagosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-5906","authenticated-orcid":false,"given":"Conxi","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Mazuelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-349X","authenticated-orcid":false,"given":"Bernat","family":"Gel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-9137","authenticated-orcid":false,"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1258-6593","authenticated-orcid":false,"given":"Meritxell","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-9857","authenticated-orcid":false,"given":"Eduard","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"73119_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1245\/s10434-012-2573-2","volume":"20","author":"J Lafemina","year":"2012","unstructured":"Lafemina, J. et al. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann. Surg. Oncol. 20, 66 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"73119_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DGR Evans","year":"2002","unstructured":"Evans, D. G. R. et al. Malignant peripheral nerve sheath tumours in neurofibromatosis. J. Med. Genet. 39, 311\u2013314 (2002).","journal-title":"J. Med. Genet."},{"key":"73119_CR3","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo, E. et al. Distinctive cancer associations in patients with neurofibromatosis type 1. J. Clin. Oncol. 34, 1978\u20131986 (2016).","journal-title":"J. Clin. Oncol."},{"key":"73119_CR4","doi-asserted-by":"publisher","first-page":"756395","DOI":"10.1155\/2009\/756395","volume":"2009","author":"DE Porter","year":"2009","unstructured":"Porter, D. E. et al. Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma 2009, 756395 (2009).","journal-title":"Sarcoma"},{"key":"73119_CR5","first-page":"417","volume":"34","author":"VM Moretti","year":"2011","unstructured":"Moretti, V. M., Crawford, E. A., Staddon, A. P., Lackman, R. D. & Ogilvie, C. M. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am. J. Clin. Oncol. Cancer Clin. Trials 34, 417\u2013421 (2011).","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"73119_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/gcc.20921","volume":"50","author":"E Beert","year":"2011","unstructured":"Beert, E. et al. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes Chromosomes Cancer 50, 1021\u20131032 (2011).","journal-title":"Genes Chromosomes Cancer"},{"key":"73119_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/humu.23552","volume":"39","author":"M Carri\u00f3","year":"2018","unstructured":"Carri\u00f3, M. et al. Analysis of intratumor heterogeneity in neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: correlating histological and genomic findings. Hum. Mutat. 39, 1112\u20131125 (2018).","journal-title":"Hum. Mutat."},{"key":"73119_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee, W. et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat. Genet. 46, 1227\u20131232 (2014).","journal-title":"Nat. Genet."},{"key":"73119_CR9","doi-asserted-by":"crossref","unstructured":"Buchstaller, J., Clapp, D. W., Parada, L. F. & Zhu, Y. Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications. Neurofibromatosis Type 1: Molecular and Cellular Biology (Springer, 2012).","DOI":"10.1007\/978-3-642-32864-0_36"},{"key":"73119_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","volume":"67","author":"MM Miettinen","year":"2017","unstructured":"Miettinen, M. M. et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview. Hum. Pathol. 67, 1\u201310 (2017).","journal-title":"Hum. Pathol."},{"key":"73119_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/neuonc\/noy013","volume":"20","author":"CS Higham","year":"2018","unstructured":"Higham, C. S. et al. The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors. Neuro-Oncol. 20, 818\u2013825 (2018).","journal-title":"Neuro-Oncol."},{"key":"73119_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc.2016.83","volume":"16","author":"I Comet","year":"2016","unstructured":"Comet, I., Riising, E. M., Leblanc, B. & Helin, K. Maintaining cell identity: PRC2-mediated regulation of transcription and cancer. Nat. Rev. Cancer 16, 803\u2013810 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"73119_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature13561","volume":"514","author":"T De Raedt","year":"2014","unstructured":"De Raedt, T. et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature 514, 247\u2013251 (2014).","journal-title":"Nature"},{"key":"73119_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/NEN.0b013e3181c55d55","volume":"69","author":"RM Verdijk","year":"2010","unstructured":"Verdijk, R. M. et al. TP53 mutation analysis of malignant peripheral nerve sheath tumors. J. Neuropathol. Exp. Neurol. 69, 16\u201326 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"73119_CR15","doi-asserted-by":"publisher","first-page":"eadt9210","DOI":"10.1126\/sciadv.adt9210","volume":"11","author":"KJ Radomska","year":"2025","unstructured":"Radomska, K. J. et al. Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model. Sci. Adv. 11, eadt9210 (2025).","journal-title":"Sci. Adv."},{"key":"73119_CR16","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1093\/hmg\/ddz095","volume":"28","author":"SD Rhodes","year":"2019","unstructured":"Rhodes, S. D. et al. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. Hum. Mol. Genet. 28, 2752\u20132762 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"73119_CR17","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-19-1429","volume":"80","author":"KE Chaney","year":"2021","unstructured":"Chaney, K. E. et al. Cdkn2a loss in a model of neurofibroma demonstrates stepwise tumor progression to atypical neurofibroma and MPNST. Cancer Res. 80, 4720\u20134730 (2021).","journal-title":"Cancer Res."},{"key":"73119_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sdata.2018.106","volume":"5","author":"M Ferrer","year":"2018","unstructured":"Ferrer, M. et al. Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived Schwann cells. Sci. Data 5, 1\u201312 (2018).","journal-title":"Sci. Data"},{"key":"73119_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1535-7163.MCT-24-1053","volume":"25","author":"KB Williams","year":"2026","unstructured":"Williams, K. B. et al. Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors. Mol. Cancer Ther. 25, 230\u2013243 (2026).","journal-title":"Mol. Cancer Ther."},{"key":"73119_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1535-7163.MCT-21-0947","volume":"21","author":"J Fern\u00e1ndez-Rodr\u00edguez","year":"2022","unstructured":"Fern\u00e1ndez-Rodr\u00edguez, J. et al. A high-throughput screening platform identifies novel combination treatments for malignant peripheral nerve sheath tumors. Mol. Cancer Ther. 21, 1246\u20131258 (2022).","journal-title":"Mol. Cancer Ther."},{"key":"73119_CR21","doi-asserted-by":"crossref","unstructured":"Mazuelas, H. et al. Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas. Cell Rep. 38, 110385 (2022).","DOI":"10.1016\/j.celrep.2022.110385"},{"key":"73119_CR22","doi-asserted-by":"publisher","first-page":"102198","DOI":"10.1016\/j.xpro.2023.102198","volume":"4","author":"H Mazuelas","year":"2023","unstructured":"Mazuelas, H. et al. Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses. STAR Protoc. 4, 102198 (2023).","journal-title":"STAR Protoc."},{"key":"73119_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01405-8","volume":"20","author":"S Benfatto","year":"2021","unstructured":"Benfatto, S. et al. Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality. Mol. Cancer 20, 1\u201322 (2021).","journal-title":"Mol. Cancer"},{"key":"73119_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00439-021-02296-x","volume":"140","author":"M Magall\u00f3n-Lorenz","year":"2021","unstructured":"Magall\u00f3n-Lorenz, M. et al. Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation. Hum. Genet. 140, 1241\u20131252 (2021).","journal-title":"Hum. Genet."},{"key":"73119_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.stemcr.2019.02.001","volume":"12","author":"M Carri\u00f3","year":"2019","unstructured":"Carri\u00f3, M. et al. Reprogramming captures the genetic and tumorigenic properties of neurofibromatosis type 1 plexiform neurofibromas. Stem Cell Rep. 12, 639 (2019).","journal-title":"Stem Cell Rep."},{"key":"73119_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-0716-2213-1_13","volume":"2474","author":"R Huang","year":"2022","unstructured":"Huang, R. A quantitative high-throughput screening data analysis pipeline for activity profiling. Methods Mol. Biol. 2474, 133\u2013145 (2022).","journal-title":"Methods Mol. Biol."},{"key":"73119_CR27","doi-asserted-by":"publisher","first-page":"e28639","DOI":"10.1002\/pbc.28639","volume":"67","author":"E Butler","year":"2020","unstructured":"Butler, E. et al. Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts. Pediatr. Blood Cancer 67, e28639 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"73119_CR28","doi-asserted-by":"publisher","first-page":"57171","DOI":"10.18632\/oncotarget.11036","volume":"7","author":"S Ahsan","year":"2016","unstructured":"Ahsan, S. et al. Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors. Oncotarget 7, 57171\u201357185 (2016).","journal-title":"Oncotarget"},{"key":"73119_CR29","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.3390\/cancers15245811","volume":"15","author":"PO Zamora","year":"2023","unstructured":"Zamora, P. O. et al. Drug responses in plexiform neurofibroma type I (PNF1) cell lines using high-throughput data and combined effectiveness and potency. Cancers 15, 5811 (2023).","journal-title":"Cancers"},{"key":"73119_CR30","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. CDK4\/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. Sci Adv. 9, eadg8876 (2023).","DOI":"10.1126\/sciadv.adg8876"},{"key":"73119_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1158\/1078-0432.CCR-24-2807","volume":"31","author":"S Ortega-Bertran","year":"2025","unstructured":"Ortega-Bertran, S. et al. Triple combination of MEK, BET, and CDK inhibitors significantly reduces human malignant peripheral nerve sheath tumors in mouse models. Clin. Cancer Res. 31, 907\u2013920 (2025).","journal-title":"Clin. Cancer Res."},{"key":"73119_CR32","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1158\/1078-0432.CCR-23-0749","volume":"29","author":"JL Kohlmeyer","year":"2023","unstructured":"Kohlmeyer, J. L. et al. CDK4\/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression. Clin. Cancer Res. 29, 3484\u20133497 (2023).","journal-title":"Clin. Cancer Res."},{"key":"73119_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-025-03845-4","volume":"25","author":"S Ortega-Bertran","year":"2025","unstructured":"Ortega-Bertran, S. et al. New models for MPNST: establishment and comprehensive characterization of two tumor cell lines. Cancer Cell Int. 25, 1\u201313 (2025).","journal-title":"Cancer Cell Int."},{"key":"73119_CR34","doi-asserted-by":"publisher","first-page":"114234","DOI":"10.1016\/j.celrep.2024.114234","volume":"43","author":"PB Kanev","year":"2024","unstructured":"Kanev, P. B. et al. A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells. Cell Rep. 43, 114234 (2024).","journal-title":"Cell Rep."},{"key":"73119_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/neuonc\/noae235","volume":"27","author":"CHG Lucas","year":"2025","unstructured":"Lucas, C. H. G. et al. Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of neurofibromatosis type 1. Neuro-Oncol. 27, 616\u2013624 (2025).","journal-title":"Neuro-Oncol."},{"key":"73119_CR36","doi-asserted-by":"crossref","unstructured":"Magall\u00f3n-Lorenz, M. et al. Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis. iScience 26, 106096 (2023).","DOI":"10.1016\/j.isci.2023.106096"},{"key":"73119_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","volume":"125","author":"TI Lee","year":"2006","unstructured":"Lee, T. I. et al. Control of developmental regulators by Polycomb in human embryonic stem. Cell 125, 301\u2013313 (2006).","journal-title":"Cell"},{"key":"73119_CR38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/gcc.20353","volume":"45","author":"T De Raedt","year":"2006","unstructured":"De Raedt, T. et al. Somatic loss of wild type NF1 allele in neurofibromas: comparison of NF1 microdeletion and non-microdeletion patients. Genes Chromosomes Cancer 45, 893\u2013904 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"73119_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1101\/gad.415507","volume":"21","author":"AP Bracken","year":"2007","unstructured":"Bracken, A. P. et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21, 525 (2007).","journal-title":"Genes Dev."},{"key":"73119_CR40","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/brain\/awt130","volume":"136","author":"JA Gomez-Sanchez","year":"2013","unstructured":"Gomez-Sanchez, J. A. et al. Epigenetic induction of the Ink4a\/Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge. Brain 136, 2262\u20132278 (2013).","journal-title":"Brain"},{"key":"73119_CR41","doi-asserted-by":"publisher","first-page":"eabo5442","DOI":"10.1126\/sciadv.abo5442","volume":"8","author":"LMN Wu","year":"2022","unstructured":"Wu, L. M. N. et al. Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. Sci. Adv. 8, eabo5442 (2022).","journal-title":"Sci. Adv."},{"key":"73119_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00401-021-02341-z","volume":"142","author":"V Kochat","year":"2021","unstructured":"Kochat, V. et al. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol. 142, 565\u2013590 (2021).","journal-title":"Acta Neuropathol."},{"key":"73119_CR43","doi-asserted-by":"publisher","first-page":"111363","DOI":"10.1016\/j.celrep.2022.111363","volume":"40","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor. Cell Rep. 40, 111363 (2022).","journal-title":"Cell Rep."},{"key":"73119_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44755-9","volume":"15","author":"HN Vasudevan","year":"2024","unstructured":"Vasudevan, H. N. et al. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. Nat. Commun. 15, 477 (2024).","journal-title":"Nat. Commun."},{"key":"73119_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1101\/gad.186601","volume":"15","author":"S Britsch","year":"2001","unstructured":"Britsch, S. et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66 (2001).","journal-title":"Genes Dev."},{"key":"73119_CR46","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1158\/0008-5472.CAN-05-3330","volume":"66","author":"SJ Miller","year":"2006","unstructured":"Miller, S. J. et al. Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res. 66, 2584\u20132591 (2006).","journal-title":"Cancer Res."},{"key":"73119_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/emmm.200900027","volume":"1","author":"SJ Miller","year":"2009","unstructured":"Miller, S. J. et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol. Med. 1, 236\u2013248 (2009).","journal-title":"EMBO Mol. Med."},{"key":"73119_CR48","doi-asserted-by":"publisher","first-page":"e1002494","DOI":"10.1371\/journal.pgen.1002494","volume":"8","author":"N Dietrich","year":"2012","unstructured":"Dietrich, N. et al. REST\u2013mediated recruitment of Polycomb repressor complexes in mammalian cells. PLoS Genet. 8, e1002494 (2012).","journal-title":"PLoS Genet."},{"key":"73119_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1158\/0008-5472.CAN-10-2799","volume":"71","author":"G Lopez","year":"2011","unstructured":"Lopez, G. et al. Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res. 71, 185\u2013196 (2011).","journal-title":"Cancer Res."},{"key":"73119_CR50","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-12-1072","volume":"18","author":"AV Patel","year":"2012","unstructured":"Patel, A. V. et al. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target. Clin. Cancer Res. 18, 5020\u20135030 (2012).","journal-title":"Clin. Cancer Res."},{"key":"73119_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.celrep.2013.12.001","volume":"6","author":"AJ Patel","year":"2014","unstructured":"Patel, A. J. et al. BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through bim induction. Cell Rep. 6, 81\u201392 (2014).","journal-title":"Cell Rep."},{"key":"73119_CR52","doi-asserted-by":"crossref","unstructured":"Sun, C. et al. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Sci. Transl. Med. 9, eaal5148 (2017).","DOI":"10.1126\/scitranslmed.aal5148"},{"key":"73119_CR53","doi-asserted-by":"publisher","first-page":"102284","DOI":"10.1016\/j.xcrm.2025.102284","volume":"6","author":"Q Xiao","year":"2025","unstructured":"Xiao, Q. et al. Combined MEK and PARP inhibition enhances radiation response in rectal cancer. Cell Rep. Med. 6, 102284 (2025).","journal-title":"Cell Rep. Med."},{"key":"73119_CR54","first-page":"1","volume":"11","author":"S Li","year":"2020","unstructured":"Li, S. et al. Pan-cancer analysis reveals synergistic effects of CDK4\/6i and PARPi combination treatment in RB-proficient and RB-deficient breast cancer cells. Cell Death Dis. 11, 1\u201316 (2020).","journal-title":"Cell Death Dis."},{"key":"73119_CR55","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Sci. Transl. Med. 9, eaal1645 (2017).","DOI":"10.1126\/scitranslmed.aal1645"},{"key":"73119_CR56","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1200\/JCO.2022.40.16_suppl.1023","volume":"40","author":"PG Aftimos","year":"2022","unstructured":"Aftimos, P. G. et al. A phase 1b\/2 study of the BET inhibitor ZEN-3694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1\/2 mutations. J. Clin. Oncol. 40, 1023\u20131023 (2022).","journal-title":"J. Clin. Oncol."},{"key":"73119_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/15384047.2015.1108486","volume":"17","author":"CM Kivlin","year":"2016","unstructured":"Kivlin, C. M. et al. Poly (ADP) ribose polymerase inhibition: a potential treatment of malignant peripheral nerve sheath tumor. Cancer Biol. Ther. 17, 129\u2013138 (2016).","journal-title":"Cancer Biol. Ther."},{"key":"73119_CR58","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/neuonc\/noad097","volume":"25","author":"AT Larsson","year":"2023","unstructured":"Larsson, A. T. et al. Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. Neuro-Oncol. 25, 2044\u20132057 (2023).","journal-title":"Neuro-Oncol."},{"key":"73119_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nprot.2012.156","volume":"8","author":"L Menendez","year":"2013","unstructured":"Menendez, L. et al. Directed differentiation of human pluripotent cells to neural crest stem cells. Nat. Protoc. 8, 203\u2013212 (2013).","journal-title":"Nat. Protoc."},{"key":"73119_CR60","first-page":"1","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Jadhav, A., Southal, N., Huang, R. & Nguyen, D. T. A grid algorithm for high throughput fitting of dose-response curve data. AACE Clin. Case Rep. 7, 1 (2021).","journal-title":"AACE Clin. Case Rep."},{"key":"73119_CR61","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440\u2013446 (2010).","journal-title":"Cancer Res."},{"key":"73119_CR62","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at arXiv https:\/\/arxiv.org\/pdf\/1303.3997 (2013)."},{"key":"73119_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, 1\u20139 (2008).","journal-title":"Genome Biol."},{"key":"73119_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"73119_CR65","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"73119_CR66","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"73119_CR67","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.105.3.608","volume":"105","author":"K DeBella","year":"2000","unstructured":"DeBella, K., Szudek, J. & Friedman, J. M. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105, 608\u2013614 (2000).","journal-title":"Pediatrics"},{"key":"73119_CR68","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/bioinformatics\/btw777","volume":"33","author":"DJ McCarthy","year":"2017","unstructured":"McCarthy, D. J., Campbell, K. R., Lun, A. T. L. & Wills, Q. F. Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics 33, 1179\u20131186 (2017).","journal-title":"Bioinformatics"},{"key":"73119_CR69","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.2","volume":"10","author":"PL Germain","year":"2022","unstructured":"Germain, P. L., Robinson, M. D., Lun, A., Garcia Meixide, C. & Macnair, W. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 10, 979 (2022).","journal-title":"F1000Res."},{"key":"73119_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi, L., Lun, A. T. L., Morgan, M. D. & Marioni, J. C. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat. Biotechnol. 36, 421\u2013427 (2018).","journal-title":"Nat. Biotechnol."},{"key":"73119_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-632","volume":"14","author":"NA Mabbott","year":"2013","unstructured":"Mabbott, N. A., Baillie, J. K., Brown, H., Freeman, T. C. & Hume, D. A. An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics 14, 1\u201313 (2013).","journal-title":"BMC Genomics"},{"key":"73119_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"73119_CR73","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"73119_CR74","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1093\/bioinformatics\/btx346","volume":"33","author":"B Gel","year":"2017","unstructured":"Gel, B. & Serra, E. karyoploteR: an R\/Bioconductor package to plot customizable genomes displaying arbitrary data. Bioinformatics 33, 3088\u20133090 (2017).","journal-title":"Bioinformatics"},{"key":"73119_CR75","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73119-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73119-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73119-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:02:20Z","timestamp":1781712140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73119-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73119"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73119-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5361"}}